Analysis
Colgate-Palmolive (CL) experienced significant financial headwinds in 2025 due to new U.S. tariffs, which management estimated at a $200M gross incremental cost for the fiscal year. These tariffs, introduced in early 2025, predominantly affected raw materials and finished goods imported from China into the United States, as well as U.S. exports to China. The company described the situation as a "key challenge" and a "fluid" environment that contributed to broader inflationary pressures and market volatility throughout the year (Transcript 1Q-2025).
To mitigate the tariff impact, the company deployed a multi-faceted strategy focused on productivity, revenue growth management (RGM), and supply chain reconfiguration. Specifically, CL leveraged its "Funding the Growth" initiatives and increased pricing to offset higher input costs. Management also highlighted that years of investment in its U.S. supply chain—totaling approximately $2B over the last five years and increasing U.S. manufacturing facilities by 40%—had provided the flexibility needed to shift production away from high-tariff regions (Transcript AGM 2025).
Despite these headwinds, Colgate-Palmolive maintained a gross profit margin above 60% for FY2025, although the non-GAAP margin declined by 50 basis points year-over-year to 60.1%. This decline was driven by a 420 basis point headwind from higher raw and packaging material costs (including tariffs and transactional FX), which was partially offset by a 260 basis point benefit from cost-savings initiatives and an 80 basis point benefit from pricing (Annual Report FY-2025).
Looking into 2026, management continues to view the geopolitical environment, including tariffs, as volatile and uncertain. The company has integrated this uncertainty into its FY2026 guidance, providing a wider-than-normal range for organic sales growth of 1% to 4%. While recent legal rulings in early 2026 have overturned certain emergency tariffs, the company remains focused on maintaining supply chain agility to navigate any lingering trade disruptions (Transcript FY-2025).
Data
($M, except margin data)
| FY2025 Gross Margin Bridge | Basis Point Impact |
|---|---|
| Raw & Packaging Materials (incl. Tariffs) | (420) bps |
| Pricing | 80 bps |
| Funding the Growth Savings | 260 bps |
| Favorable Mix | 30 bps |
| Total Non-GAAP Margin Change | (50) bps |
| Tariff Financial Data | FY2025 Impact |
|---|---|
| Estimated Gross Tariff Headwind | $200.0 |
Source: Annual Report FY-2025, Transcript AGM 2025, Marvin Labs
Financial Impact
- Cost Impact (Historic): $200M
Sources
We announced an estimated $200mn impact from tariffs that are in effect right now, predominantly tariffs on goods and raw materials coming out of China into the U.S. and from the U.S. into China.
Despite the significant tariff headwinds that we had in 2025, we're still over a 60% gross profit, which is terrific.
As I mentioned on the Q4 call, we have changed many of our sourcing strategies and have also invested approximately $2bn in our supply chain in the United States over the past five years, which leaves us better positioned to adapt to this changing environment.